451 related articles for article (PubMed ID: 19147348)
1. Synthesis and SAR of vinca alkaloid analogues.
Voss ME; Ralph JM; Xie D; Manning DD; Chen X; Frank AJ; Leyhane AJ; Liu L; Stevens JM; Budde C; Surman MD; Friedrich T; Peace D; Scott IL; Wolf M; Johnson R
Bioorg Med Chem Lett; 2009 Feb; 19(4):1245-9. PubMed ID: 19147348
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of fluorinated catharanthine analogues and investigation of their biomimetic coupling with vindoline.
Giovanelli E; Moisan L; Comesse S; Leroux S; Rousseau B; Hellier P; Nicolas M; Doris E
Org Biomol Chem; 2013 Sep; 11(35):5885-91. PubMed ID: 23903701
[TBL] [Abstract][Full Text] [Related]
3. New semisynthetic vinca alkaloids: chemical, biochemical and cellular studies.
Orosz F; Comin B; Raïs B; Puigjaner J; Kovács J; Tárkányi G; Acs T; Keve T; Cascante M; Ovádi J
Br J Cancer; 1999 Mar; 79(9-10):1356-65. PubMed ID: 10188876
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of vinca alkaloids and related compounds, Part XCVI. Nitration study of vinblastine-type bisindole alkaloids.
Szabó L; Bölcskei H; Eszter BG; Mák M; Szántay C
Arch Pharm (Weinheim); 2001 Dec; 334(12):399-405. PubMed ID: 11852536
[TBL] [Abstract][Full Text] [Related]
5. Total synthesis and biological evaluation of jerantinine E.
Frei R; Staedler D; Raja A; Franke R; Sasse F; Gerber-Lemaire S; Waser J
Angew Chem Int Ed Engl; 2013 Dec; 52(50):13373-6. PubMed ID: 24127420
[No Abstract] [Full Text] [Related]
6. [New antitumor derivatives of vinblastine].
Bölcskei H; Szántay C; Mák M; Balázs M; Szántay C
Acta Pharm Hung; 1998 Mar; 68(2):87-93. PubMed ID: 9592933
[TBL] [Abstract][Full Text] [Related]
7. Positive interaction of bisbenzylisoquinoline alkaloid, cepharanthin, with vinca alkaloid agents against human tumors.
Ono M; Tanaka N
In Vivo; 1997; 11(3):233-41. PubMed ID: 9239517
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of C-12' substituted vinflunine derivatives.
Lei XS; Yu XD; Yin L; Liu ZH; Tang PC
Bioorg Med Chem Lett; 2008 Aug; 18(16):4602-5. PubMed ID: 18653334
[TBL] [Abstract][Full Text] [Related]
9. Elaboration of thorough simplified vinca alkaloids as antimitotic agents based on pharmacophore similarity.
Zheng J; Deng L; Chen M; Xiao X; Xiao S; Guo C; Xiao G; Bai L; Ye W; Zhang D; Chen H
Eur J Med Chem; 2013 Jul; 65():158-67. PubMed ID: 23708010
[TBL] [Abstract][Full Text] [Related]
10. Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties.
Kruczynski A; Hill BT
Crit Rev Oncol Hematol; 2001 Nov; 40(2):159-73. PubMed ID: 11682323
[TBL] [Abstract][Full Text] [Related]
11. The effect of vindoline C-16 substituents on the biomimetic coupling reaction: synthesis and cytotoxicity evaluation of the corresponding vinorelbine analogues.
Song W; Hu L; Meng Y; Ma L; Guo D; Liu X; Hu L
Bioorg Med Chem Lett; 2012 May; 22(10):3485-7. PubMed ID: 22525316
[TBL] [Abstract][Full Text] [Related]
12. Direct coupling of catharanthine and vindoline to provide vinblastine: total synthesis of (+)- and ent-(-)-vinblastine.
Ishikawa H; Colby DA; Boger DL
J Am Chem Soc; 2008 Jan; 130(2):420-1. PubMed ID: 18081297
[TBL] [Abstract][Full Text] [Related]
13. The synthesis of Navelbine prototype of a new series of vinblastine derivatives.
Potier P
Semin Oncol; 1989 Apr; 16(2 Suppl 4):2-4. PubMed ID: 2540531
[No Abstract] [Full Text] [Related]
14. New compounds with cytotoxic and antitumor effects. Part 6: Monomeric indole alkaloids of vinca minor L. and their effect on P388 cells.
Sturdíková M; Fuska J; Grossmann E; Votický Z
Pharmazie; 1986 Apr; 41(4):270-2. PubMed ID: 3725874
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacology of Catharanthus alkaloids].
Levêque D; Wihlm J; Jehl F
Bull Cancer; 1996 Mar; 83(3):176-86. PubMed ID: 8695919
[TBL] [Abstract][Full Text] [Related]
16. Riboflavin-mediated photosensitization of Vinca alkaloids distorts drug sensitivity assays.
Granzow C; Kopun M; Kröber T
Cancer Res; 1995 Nov; 55(21):4837-43. PubMed ID: 7585517
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the pharmacological antitumor effects of S 12363, a new vinca alkaloid.
Atassi G; Berlion M; el Oche Y; Bizzari JP
Anticancer Res; 1991; 11(2):975-80. PubMed ID: 2064354
[TBL] [Abstract][Full Text] [Related]
18. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate.
Wilkoff LJ; Dulmadge EA
J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of K-ras-expressing tumours by a new vinca alkaloid, conophylline, in nude mice.
Umezawa K; Taniguchi T; Toi M; Ohse T; Tsutsumi N; Yamamoto T; Koyano T; Ishizuka M
Drugs Exp Clin Res; 1996; 22(2):35-40. PubMed ID: 8879977
[TBL] [Abstract][Full Text] [Related]
20. Experimental in vivo cross-resistance of vinca alkaloid drugs.
Maral R; Bourut C; Chenu E; Mathe G
Cancer Chemother Pharmacol; 1981; 5(3):197-9. PubMed ID: 7296754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
